Wednesday, November 11, 2020 Pre-Meeting Sessions
Conversation With the Professor
8:30
Chat With:
Jeffrey Joseph, DO
Thomas Jefferson University, Philadelphia, Pennsylvania, USA
9:00
Chat With:
Boris Kovatchev, PhD
University of Virginia, Charlottesville, Virginia, USA
9:30
Chat With:
Lutz Heinemann, PhD
Science Consulting in Diabetes GmbH, Neuss, Germany
Product Theater
10:00
Ascensia Presents: CGM and Telehealth, Before, During, and After COVID-19
Francine R. Kauffman, MD
Chief Medical Officer, Senseonics, Inc., Germantown, Maryland, USA
11:00
Lifescan Presents: HCP Perceptions of the Clinical Value and Utility of Current Blood Glucose Meters (CONVINCE Study)
Mike Grady, MSc, PhD
Director WW Clinical Affairs
LifeScan, Inverness, United Kingdom
11:30
Abbott Diabetes Care Presents: Introducing the FreeStyle Libre 2 System
Eden Miller, DO
High Lakes Health Care, Bend, Oregon, USA
12:00
BD Presents: When Insulin Injection Depth is Too Deep: What Happens and How to Prevent It
Timothy S. Bailey, MD, FACE, CPI
President & CEO AMCR Institute, Escondido, California, USA
Clinical Associate Professor, UCSD School of Medicine, La Jolla, California, USA
Brian K Pflug, PharmD
Global Medical Director US/Canada
BD Diabetes Care Medical Affairs, Franklin Lakes, New Jersey, USA
12:30
Dexcom Presents: The Role of Continuous Data in Remote Patient Monitoring
Egils Bogdanovics, MD
Charlotte Hungerford Hospital, Torrington, Connecticut, USA
Adam Wolfberg, MD, MPH
Chief Medical Officer, Current Health, New York City, New York, USA
1:00
Glytec Presents: Insulin Management Optimized. Uniting Your Team on Patient Safety
Andy O’Dell
Regional Vice President
Glytec, Atlanta, Georgia, USA
Jordan Messler, MD, SFHM, FACP
Executive Director, Clinical Practice
Glytec, Largo, Florida, USA
Thursday, November 12, 2020
Workshop 1: Novel Software
Panel 1: Artificial Intelligence
8:00
Moderators:
Wayne Bequette, PhD
Rensselaer Polytechnic Institute, Troy, New York, USA
Piotr Ladyzynski, PhD
Nalecz Institute of Biocybernetics and Biomedical Engineering of the Polish Academy of Sciences, Warsaw, Poland
8:05
CGM-AI: From Pattern Recognition to Automatic Control
Boris Kovatchev, PhD
University of Virginia, Charlottesville, Virginia, USA
8:20
Clinical Uses of Artificial Intelligence
Moshe Phillip, MD
National Center for Childhood Diabetes, Schneider Children's Medical Center of Israel, Petah Tikva, Israel
8:35
Use of Artificial Intelligence in the Design of Decision Support Systems
Peter Jacobs, PhD
Oregon Health and Science University, Portland, Oregon, USA
8:50
An Artificial Intelligence Augmented Mobile APP
Mercedes Rigla, MD, PhD
Parc Taulí Sabadell University Hospital, Barcelona, Spain
9:05
Q&A / Panel Discussion
9:30
Break
Panel 2: Digital Health and Telemedicine
9:55
Moderators:
David Ahn, MD
Mary & Dick Allen Diabetes Center at Hoag, Newport Beach, California, USA
Jennifer Raymond, MD, MCR
University of Southern California, Los Angeles, California, USA
10:00
Diabetes Telehealth: We’re Doing It… But How Do We Make It Better & Easier?
Aaron Neinstein, MD
UCSF, San Francisco, California, USA
10:15
Integrated Personalized Diabetes Management (IPDM) In an Open Ecosystem – Paving the Way for Advanced Outcomes in Diabetes Therapy
Rolf Hinzmann, MD, PhD
Roche Diagnostics, Manheim, Germany
10:30
Digital Health Tools to Improve Adherence to Blood Glucose Monitoring
Elizabeth Holt, MD, FACE
Lifescan, Wayne, Pennsylvania, USA
10:45
The Benefits of a Multi-Sensor Platform for Diabetes
Mark Clements, MD, PhD
Glooko, Mountain View, California, USA
11:00
Telemedicine to Support Personalized Care
Ronald Dixon, MD
Remedy, Austin, Texas, USA
11:15
Q&A
11:40
Lunch
Workshop 2: Glucose Monitoring
Panel 1: Noninvasive
12:40
Moderators:
Gerard Coté, PhD
Texas A & M University, College Station, Texas, USA
Brian Frier, BSc (Hons), MD, FRCP(Edin), FRCP(Glas)
University of Edinburgh, Edinburgh, Scotland
12:45
Fundamental Issues That Limit Successful Non-Invasive Glucose Measurements
Mark Arnold, PhD
University of Iowa, Iowa City, Iowa, USA
13:00
Optical Methods for Non-Invasive Glucose Sensing – Breakthrough or Broken Promises Again?
Michael Heise, PhD
South-Westphalia University of Applied Science, Iserlohn, Germany
13:15
Detection of Hypoglycemia with Non-Invasive Sensors in Subjects with Impaired Awareness of Hypoglycemia.
Kåre Birkeland, MD
Aker University Hospital, Oslo, Norway
13:30
Tear Glucose: Fact or Fiction?
Christopher Wilson, PhD
Listerdale Lifescience BV, Nijmegen, Netherlands
13:45
Skin-Interfaced Wearable Sweat Biosensors
Wei Gao, PhD
California Institute of Technology, Pasadena, California, USA
14:00
Q&A
14:20
Break
Panel 2: Novel Technologies in CGMs
14:45
Moderators:
Jennifer Sherr, MD, PhD
Yale University, New Haven, Connecticut, USA
Hubert Vesper, PhD
Centers for Disease Control and Prevention, Atlanta, Georgia, USA
14:50
CGM Usage for the Management and Reversal of Type 2 Diabetes
Faz Chowdhury, PhD
CEO, Nemaura Medical, Loughborough, UK
15:05
Senseonics Eversense CGM System
Francine Kaufman, MD
Senseonics, Germantown, Maryland, USA
Andreas Stuhr, MD, MBA
Ascensia Diabetes Care, Parsippany, New Jersey, USA
15:20
Waveform Technologies
Mihailo Rebec, PhD
Waveform Technologies, Wilsonville, Oregon, USA
15:35
Performance of a Next Generation iCGM System
Marc Taub, PhD
Abbott Diabetes Care, Alameda, California, USA
15:50
Dexcom Technologies
Peter Simpson, MS
DexCom, Inc., San Diego, California, USA
16:05
Integrated CGM Systems – Enabling Technologies for Usability & Comfort
Akhil Srinivasan, PhD
Medtronic Diabetes, Washington DC, USA
16:20
Q&A / Panel Discussion
16:45
End of Workshop
Friday, November 13, 2020
8:00
Introduction
David Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE
Mills-Peninsula Medical Center, San Mateo, California, USA
8:05
Regulatory Trends at the FDA in Diabetes Devices
Timothy Stenzel, MD, PhD
Director, Office of In Vitro Diagnostics and Radiological Health at the FDA, Silver Spring, Maryland, USA
Session 1: What Are the Best Metrics for Expressing Glycemia in CGM?
8:30
Moderators:
Guillermo Arreaza-Rubin, MD
NIDDK/NIH, Bethesda, Maryland, USA
Jessica Castle, MD
Oregon Health Sciences University, Portland, Oregon, USA
8:30
Time-In-Range or HbA1c: Why Not Both?
Lutz Heinemann, PhD
Science Consulting in Diabetes GmbH, Neuss, Germany
8:40
Metrics for Evaluation of Quality of Glycemic Control
David Rodbard, MD
Biomedical Informatics Consultants LLC, Potomac, Maryland, USA
8:50
Essential Metrics: The Principal Components of a CGM Daily Profile
Boris Kovatchev, PhD
University of Virginia, Charlottesville, Virginia, USA
9:00
Interconnected Relationships of Metrics in the AGP
Richard Bergenstal, MD
International Diabetes Center, Minneapolis, Minnesota, USA
9:10
Q&A / Panel Discussion
Session 2: What role does BGM have in the future?
9:40
Moderators:
Robert Gabbay, MD, PhD
Chief Scientific and Medical Officer, American Diabetes Association, Arlington, Virginia, USA
John Pickup, MA, BM, DPhil, DSc, FRCPath
King's College London, London, United Kingdom
Presentation of Diabetes Technology Leadership Award
9:45
BGM in the 21st Century: A Perspective
Robert Schumm, MBA
President, Ascensia Diabetes Care, Basel, Switzerland
9:55
Applications of BGM
Richard Bergenstal, MD
International Diabetes Center, Minneapolis, Minnesota, USA
10:05
Is BGM Dead?
Steven Edelman, MD
Veterans Affairs Medical Center, UC San Diego, La Jolla, California, USA
10:15
Blood Glucose Assessment in a Digitalized Sensor Ecosystem Environment – Future Perspectives
Andreas Pfützner, MD, PhD
Pfützner Science and Health Institute, Mainz, Germany
10:25
Trends in Capillary BGM
Irl Hirsch, MD
University of Washington School of Medicine, Seattle, Washington, USA
10:35
Q&A / Panel Discussions
11:00
Break
Session 3: What are recent developments in regulatory science for diabetes devices?
11:25
Moderators:
Alberto Gutierrez, PhD
NDA Partners, LLC, Rochelle, Virginia, USA
Yarmela Pavlovic, JD
Manatt Health, San Francisco, California, USA
11:35
Insulin Dosing Software
Naomi Schwartz, MS
FDA, Silver Spring, Maryland, USA
11:45
Automated Insulin Dosing Systems
Yiduo Wu, PhD
FDA, Silver Spring, Maryland, USA
11:55
Cybersecurity
Suzanne Schwartz, MD, MBA
FDA, Silver Spring, Maryland, USA
12:05
Real World Evidence
Ken Quinto, MD, MPH
FDA, Silver Spring, Maryland, USA
12:15
Q&A / Panel Discussion
12:40
Lunch
Session 4: What is the role of pharma in Digital Health?
13:35
Moderators:
Juan Espinoza, MD, FAAP
University of Southern California, Los Angeles, California, USA
Matthew Taylor, CFA
MedTech Supplies & Devices Analyst, UBS-ARC, New York, New York, USA
13:40
Diabetes Is a Wicked Problem
David Kerr, MBChB, DM, FRCP, FRCPE
Sansum Diabetes Research Institute, Santa Barbara, California, USA
13:50
Unleashing the Potential of Connected Insulin Pens
Howard Wolpert, MD
Lilly Cambridge Innovation Center, Cambridge, Massachusetts, USA
14:00
New Components for the Virtual Digital Diabetes Clinic That Will Improve Outcomes and Efficiency
Anders Toft, MD, PhD, eMBA
Novo Nordisk, Copenhagen, Denmark
14:10
Levels of Complexity and Reward from Digital Health
Christopher Boulton, BSc
Sanofi, Bridgewater, New Jersey, USA
14:20
Digital Health Change How Patients Are Using Drugs: A New Parameter in Drug Development
Sam Collaudin, PhD, jMBA
Quarterly R&D Diabetes News Report, Marburg, Germany
14:30
Q&A / Panel Discussion
Session 5: Artificial Pancreas (What do patients like and dislike about their automated insulin delivery systems?)
15:05
Moderators:
Bruce Buckingham, MD
Stanford University, Palo Alto, California, USA
Alexander Fleming, MD
Kinexum Services LLC, Harpers Ferry, West Virginia, USA
15:10
Patient Panel (Users of Four Automated Insulin Delivery Systems)
15:30
Break
Session 6: Can we build a fully automated AP without pre-meal announcements?
15:50
Moderators:
Jeffrey Joseph, DO
Thomas Jefferson University, Philadelphia, Pennsylvania, USA
Laurel Messer, PhD, RN, CDCES
Barbara Davis Center for Childhood Diabetes, Aurora, Colorado, USA
Presentation of Artificial Pancreas Award
15:55
Anticipating Glycemic Disturbances to Control Unannounced Meals and Exercise
Marc Breton, PhD
University of Virginia, Charlottesville, Virginia, USA
16:07
Fully Automated AP Without Pre-Meal Announcements
Ali Cinar, PhD
Illinois Institute of Technology, Chicago, Illinois, USA
16:19
Eliminating Meal Announcements
Roman Hovorka, PhD, FMedSci
University of Cambridge, Cambridge, UK
16:31
Multivariable Control for the Artificial Pancreas
Frank Doyle, PhD, CPGS
Dean, Harvard John A. Paulson School of Engineering & Applied Sciences, Cambridge, Massachusetts, USA
16:43
Q&A / Panel Discussion
17:00
End of Session
Saturday, November 14, 2020
Session 7: What is the role of ultra short acting and ultra long acting analog insulins?
7:50
Moderators
Gerold Grodsky, PhD
UCSF, San Francisco, California, USA
Tim Heise, MD
Profil, Neuss, Germany
Presentation of Student Research Awards
8:05
The Clinical Need for Ultra Short Acting and Ultra Long Acting Analog Insulins
Anne Peters, MD, FACP, CDE
University of Southern California, Los Angeles, California, USA
8:15
Ultrarapid Insulin Aspart Injection (Fiasp Insulin). What Will Be Its Role?
Athena Philis-Tsimikas, MD
Scripps Whittier Institute for Diabetes, UC San Diego, San Diego, California, USA
8:25
Ultrarapid Lispro (Lyujev) Insulin. What Will Be Its Role?
Leslie Klaff, MD, PhD
Rainier Clinical Research, Renton, Washington, USA
8:35
Hepatic Directed Insulin
Bruce Bode, MD
Atlanta Diabetes Associates, Atlanta, Georgia, USA
8:45
Inhaled Insulin for Pulmonary Delivery
Eda Cengiz, MD, FAAP, MHS
Yale University School of Medicine, New Haven, Connecticut, USA
8:55
Weekly Basal Insulin Icodec…The Way of the Future!
Julio Rosenstock, MD
Dallas Diabetes and Endocrine Center, Dallas, Texas, USA
9:05
Q&A / Panel Discussion
9:20
End of Session
Session 8: How should the performance of CGM systems be evaluated?
9:20
Moderators:
Craig Kollman, PhD
Jaeb Center for Health Research, Tampa, Florida, USA
Carlos Mendez, MD, FACP
Medical College of Wisconsin, Milwaukee, Wisconsin, USA
9:25
CGM Accuracy – A Clinical Perspective
Tim Bailey, MD, FACE, FACP, CPI
AMCR Institute, Escondido, California, USA
9:40
A Review of the Proposed Performance Metrics for Continuous Interstitial Glucose Monitoring, Under Development by the Clinical and Laboratory Standards Institute (CLSI)
David Horwitz, MD, PhD
DLH Biomedical Consulting LLC, Las Vegas, Nevada, USA
9:55
IFCC CGM-WG: Improving Standardization of Continuous Glucose Monitoring
Guido Freckmann, MD
Institute for Diabetes Technology GmbH, Ulm, Germany
10:10
The DTS Guideline for Continuous Glucose Monitors and Automated Insulin Dosing Systems in the Hospital
Rodolfo Galindo, MD, FACE
Emory University School of Medicine, Atlanta, Georgia, USA
10:25
How the Security Performance of CGMs (And Other Connected Diabetes Devices) Should Be Evaluated
David Kleidermacher, BS
Google, Mountain View, California, USA
10:40
Q&A / Panel Discussion
10:55
Break
Session 9: Is digital health discriminatory?
11:20
Moderators:
Andrew Bremer, MD, PhD
NIDDK/National Institutes of Health, Bethesda, Maryland, USA
Sarah Kim, MD
UCSF, San Francisco, California, USA
11:20
Technology Is Not the Silver Bullet
Fazlyn Petersen, PhD
University of Western Cape, Cape Town, South Africa
11:30
Digital Health in the Military
Karl Friedl, PhD, COL
USAMRMC/Telemedicine and Advanced Tech Research Center, Fort Detrick, Maryland, USA
11:40
A Level Playing Field
Celeste Campos-Castillo, PhD
University of Wisconsin Milwaukee, Milwaukee, Wisconsin, USA
11:50
Developing Technology for Digital Health
Keesha Perkins-Crosby, MS
Tri-Guard Risk Solutions, LTD, Arlington, Virginia, USA
12:00
Technology Capacity and Literacy for Urban Poor
Elizabeth Burner, MD, MPH
University of Southern California, Los Angeles, California, USA
12:10
Q&A / Panel Discussion
12:25
Lunch
Session 10: Does real time diabetes monitoring require more metrics than glucose?
13:20
Moderators:
Avner Gal, MBA., MSCEE, MSc
Iridium Consultancy and Technologies, Ltd., Herzliya, Israel
Barry Ginsberg, MD, PhD
Diabetes Technology Consultants, Wyckoff, New Jersey, USA
13:25
Smart Insulin Pens
Hope Warshaw, MMSc, RD, CDCES, BC-ADM
Hope Warshaw Associates, Alexandria, Virginia, USA
13:35
Use of Exercise Monitors to Provide Additional Information for Monitoring Diabetes
Dessi Zaharieva, PhD
Stanford University, Palo Alto, California, USA
13:45
Use of Activity Data from Wearable Trackers in T2D Research
Christian Cerrada, PhD
Evidation Health, Inc., San Mateo, California, USA
13:55
Multi-Sensor Platforms
Jeffrey Joseph, DO
Thomas Jefferson University, Philadelphia, Pennsylvania, USA
14:05
Sensors to Prevent, Monitor, and Treat Foot Ulcers
Bijan Najafi, PhD
Baylor College of Medicine, Houston, Texas, USA
14:15
Q&A / Panel Discussion
14:30
Break
Session 11: Can glucose monitoring predict the future?
14:50
Moderators:
Thanh Hoang, DO
Walter Reed National Military Medical Center, Bethesda, Maryland, USA
Umesh Masharani, MD
UCSF, San Francisco, California, USA
14:55
CGM-Informed Prediction Tools
Chiara Fabris, PhD
University of Virginia, Charlottesville, Virginia, USA
15:05
Classification of Hypoglycemia – The Hypo-RESOLVE Project
Bastiaan de Galan, MD, PhD
Maastricht University Medical Centre, Maastricht, Netherlands
Radboud University Medical Centre, Nijmegen, Netherlands
15:15
Low Sensor Glucose and Hypoglycemia – Are They the Same? The HypoMETRICS Project
Pratik Choudhary, MBBD, MRCP, MD
University of Leicester, Leicester, UK
15:25
Yes, Glucose Monitoring Can Predict the Future
Dan Goldner, PhD
One Drop, New York, New York, USA
15:35
Simplifying Diabetes Management Through Glucose Prediction
Pratik Agrawal, MS
Medtronic Diabetes, Northridge, California, USA
15:45
Software to Achieve Target Glycemia
Jordan Messler, MD, SFHM, FACP
Glytec, Largo, Florida, USA
15:55
Q&A / Panel Discussion
16:10
End of Session
Live Demonstration
16:10
Moderators:
Rodolfo Galindo, MD, FACE
Emory University School of Medicine, Atlanta, Georgia, USA
Eun-Jung Rhee, MD, PhD
Kangbuk Samsung Hospital, Seoul, South Korea
16:15
Smart Socks for Diabetic Foot Ulcers
Bijan Najafi, PhD
Baylor College of Medicine, Houston, Texas, USA
16:40
Closing Statements
David Kerr, MBChB, DM, FRCP, FRCPE
Sansum Diabetes Research Institute, Santa Barbara, California, USA
16:45
End
Thursday, November 19, 2020
Virtual Poster Session
Session A
Moderators:
Shashank Joshi, MD, DM, FICP, FACP(USA), FACE(USA), FRCP(Lon,Glsg & Edin)
Lilavati Hospital and Research Centre, Mumbai, India
Julia Mader, MD, PhD
Medical University of Graz, Graz, Austria
8:30
Impact of the MiniMed™ AHCL system on post-prandial glucose after a missed meal bolus in adolescents and adults with type 1 diabetes (T1D)
Jennifer Sherr, MD, PhD et al.
8:34
Individualized Linear Models for Glucose Prediction: Parametric vs. Non-Parametric Identification
Simone Faccioli, MSc et al.
8:38
Classification of Daily Continuous Glucose Monitoring (CGM) Profiles in Type 1 Diabetes Using Layered Clustering and Clinical Metrics
Mahdi Shafiei, PhD et al.
8:42
Pulsatile Insulin Treatment as a Treatment Option for Patients with Type 2 Diabetes and Stage III Kidney Failure – Results from a Pilot Study
Andreas Pfützner, MD, PhD et al.
8:46
The Burden of Hypoglycemia during Real-World Conditions
Felix Aberer, MD et al.
8:50
A New Model for Mealtime Insulin Dosing in Type 1 Diabetes: Retrospective Validation on CTR3 Dataset
Giulia Noaro, MSc et al.
8:54
Q & A / Panel Discussion
Session B
Moderators:
John Nolan, MD, FRCPI, FRCP(Ed), FTCD (hon)
Trinity College Dublin, Dublin, Ireland
Gerry Rayman, MD, FRCP
The Ipswich Diabetes Centre Ipswich Hospital, Ipswich, UK
9:15
Predicting Blood Glucose Levels Using CNN-LSTM Neural Networks
Mehrad Jaloli, MSc et al.
9:19
Determining the Optimal Duration of a Clinical Trial Having Time-in-ranges as Final Endpoints
Nunzio Camerlingo, MSc et al.
9:23
Highly Miniaturized, Low Power CMOS ASIC for Long-Term, Needle-Implantable CGMs
Raja Hari Gudlavalleti, MS et al.
9:27
Expected Variability in Estimated Insulin Secretion from C-peptide using Van Cauter Kinetic Parameters
Jennifer J. Ormsbee, MSc et al.
9:31
Preliminary Assessment of a Mass Manufacturable Point-of-Care Insulin Sensor
Madison Strong, NONE et al.
9:35
Intravenous Automated Blood Glucose Control with No Meal Announcement. A Prospective Time-in-Range In Silico Study
Adrian Tarniceriu, PhD et al.
9:39
Q & A / Panel Discussion
Session C
Moderators:
Lori Laffel, MD, MPH
Joslin Diabetes Center Harvard Medical School, Boston, Massachusetts, USA
Nestoras Mathioudakis, MD
Johns Hopkins University, Baltimore, Maryland, USA
10:00
Variations in Time in Range Assessed by CGM in the Early COVID-19 Pandemic
Joost van der Linden, PhD et al.
10:04
A Massive Open Online Course for Type 2 Diabetes Self-Management: Adapting Education in the COVID-19 Era
Scott Mackenzie, BMSc (Hons) MBChB et al.
10:08
Use of the Sencell Osmotic Pressure-Based Glucose Sensor in a Standard Needle Sensor Environment
Andreas Pfützner, MD, PhD et al.
10:12
Insulin Cost-Savings Comparison: 7-Day Extended Wear Infusion Set with Medtronic Pump vs. 2-3 Day Wear Infusion Set with Non-Medtronic Pump
Sarnath Chattaraj, PhD et al.
10:16
Role of Site Selection & Cannula Length in Insulin Infusion Set Performance
Gina Zhang, PhD et al.
10:20
Insulin, Not the Preservative m-Cresol, Instigates Loss of Infusion Site Patency Over Extended Durations of CSII in Diabetic Swine
Monica Swinney, PhD et al.
10:24
Q & A / Panel Discussion
Session D
Moderators:
Sanjoy Dutta, PhD
Juvenile Diabetes Research Foundation, New York, New York. USA
Boris Mankovsky, MD, PhD
Institute of Endocrinology, Kiev, Ukraine
10:45
Persistent Hyperglycemia in Extremely Low Birth Weight Premature Infants
Jennifer Knopp, PhD et al.
10:49
Significant Reduction in Time-Below-Range (Hypoglycemia) in People with Type 1 Diabetes using an Advanced Hybrid Closed Loop System
Lars Mueller, PhD et al.
10:53
The Effect of a Digital Therapeutic Platform on Glycemic Control in Adults above Age 65 with Type 2 Diabetes
Yifat Hershcovitz, PhD et al.
10:57
Differences in Perceived Quality of Sleep and Satisfaction with Insulin Delivery Device in People with Diabetes
Harsimran Singh, PhD et al.
Oral Presentation by Steph Habif, EdD, MS
11:01
Smart Insulin Pens Allow Correction Doses Between Meals as Needed Without Compromising Time Below Range
Madison Smith, PhD, RN, CDCES et al.
11:05
The Extended Wear Infusion Set- A Design for Plastic Waste Reduction
Hsi Fusselman, MS et al.
11:09
Q & A / Panel Discussion
Session E
Moderators:
Amisha Wallia, MD, MS
Northwestern Unviersity, Chicago, Illinois, USA
Jenise Wong, MD, PhD
UCSF, San Francisco, California, USA
11:30
Diminished Weekday/Weekend Differences in Glycemic Control in the COVID-19 Pandemic
Robert Dowd, BS et al.
11:34
The Impact of a Prolonged Lockdown and Use of Telemedicine on Glycemic Control in People with Type 1 Diabetes During the COVID-19 Outbreak in Saudi Arabia
Sahar Alharthi, MBBS et al.
11:38
Glycemic Outcomes with Adjustable Settings in the Advanced Hybrid Closed-loop (AHCL) System-Pivotal Trial
Anirban Roy, PhD et al.
11:42
Deteriorating Glucose Control in Patients With Diabetes (PWD) after Disengagement From A Mobile Health (mHealth) App
Sarine Babikian, PhD et al.
Oral Presentation by Mark Clements, MD, PhD
11:46
Simulation Platform Development for Diabetes and Technology Self-Management
Eileen Faulds, PhD, MS, RN et al.
11:50
Early Insights from a Digitally Enhanced Diabetes Self-Management Education and Support Program
Folasade Wilson-Anumudu, MPH et al.
11:54
Q & A / Panel Discussion
Session F
Moderators:
Francisco Pasquel, MD, MPH
Emory University, Atlanta, Georgia, USA
Louis Philipson, MD, PhD
University of Chicago, Chicago, Illinois, USA
12:15
Regional COVID-19 Disease Burden and Individual Changes in Glycemic Control
Joost van der Linden, PhD et al.
12:19
Performance of a Factory-Calibrated Continuous Glucose Monitoring (CGM) System with a Retuned Algorithm
Xiaohe Zhang, MS et al.
Oral Presentation by Rebecca Harvey Towers, PhD
12:23
Closed-Loop Insulin Delivery in Adults with Highly Unstable Type 1 Diabetes Can Outperform Suspend-Before-Low Insulin Pump Technology, a 16-Week Randomized Crossover Trial
Pierre Yves Benhamou, MD et al.
12:27
Cost-utility of an online education platform and diabetes personal health record: analysis over ten years
Scott Cunningham, PhD et al.
12:31
Web-based Simulation Tool for Self-Management Support in Type 1 Diabetes
Patricio Colmegna, PhD et al.
12:35
Predicting Success with a Diabetes mHealth Application from Early Usage Data
Maya Mudambi, MCIT, BA et al.
12:39
Q & A / Panel Discussion